Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
Identifieur interne : 000591 ( PubMed/Checkpoint ); précédent : 000590; suivant : 000592Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
Auteurs : Jorge Gandía [Espagne] ; Xavier Morat [Espagne] ; Igor Stagljar [Canada] ; Víctor Fernández-Due As [Espagne] ; Francisco Ciruela [Belgique]Source :
- Behavioural brain research [ 1872-7549 ] ; 2015.
English descriptors
- KwdEn :
- Adenosine A2 Receptor Antagonists (pharmacology), Animals, Jaw (drug effects), Jaw (physiopathology), Male, Mice, Inbred C57BL, Mice, Knockout, Movement (drug effects), Movement (physiology), Muscarinic Antagonists (pharmacology), Parkinsonian Disorders (drug therapy), Parkinsonian Disorders (physiopathology), Pilocarpine, Pyrimidines (pharmacology), Receptor, Adenosine A2A (metabolism), Receptors, G-Protein-Coupled (genetics), Receptors, G-Protein-Coupled (metabolism), Tremor (drug therapy), Tremor (physiopathology), Triazoles (pharmacology), Tropicamide (pharmacology).
- MESH :
- chemical , genetics : Receptors, G-Protein-Coupled.
- chemical , metabolism : Receptor, Adenosine A2A, Receptors, G-Protein-Coupled.
- chemical , pharmacology : Adenosine A2 Receptor Antagonists, Muscarinic Antagonists, Pyrimidines, Triazoles, Tropicamide.
- drug effects : Jaw, Movement.
- drug therapy : Parkinsonian Disorders, Tremor.
- physiology : Movement.
- physiopathology : Jaw, Parkinsonian Disorders, Tremor.
- Animals, Male, Mice, Inbred C57BL, Mice, Knockout, Pilocarpine.
Abstract
GPR37, also known as parkin associated endothelin-like receptor (Pael-R), is an orphan GPCR that aggregates intracellularly in a juvenile form of Parkinson's disease. However, little is known about the function of this orphan receptor. Here, using a model for parkisonian tremor, the pilocarpine-induced tremulous jaw movements (TJMs), we show that the deletion of GPR37 attenuated the TJMs in response to this cholinomimetic. Interestingly, the control that adenosine A2A receptor exerted over TJMs was lost in the absence of GPR37, thus pointing to a pivotal role of this orphan receptor in the adenosinergic control of parkinsonian tremor.
DOI: 10.1016/j.bbr.2015.04.001
PubMed: 25862943
Affiliations:
- Belgique, Canada, Espagne
- Catalogne, Ontario, Province de Flandre-Orientale
- Barcelone, Gand, Toronto
- Université de Barcelone, Université de Toronto
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25862943Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.</title><author><name sortKey="Gandia, Jorge" sort="Gandia, Jorge" uniqKey="Gandia J" first="Jorge" last="Gandía">Jorge Gandía</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author><author><name sortKey="Morat, Xavier" sort="Morat, Xavier" uniqKey="Morat X" first="Xavier" last="Morat">Xavier Morat</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author><author><name sortKey="Stagljar, Igor" sort="Stagljar, Igor" uniqKey="Stagljar I" first="Igor" last="Stagljar">Igor Stagljar</name><affiliation wicri:level="4"><nlm:affiliation>Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, Donnelly Centre, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Fernandez Due As, Victor" sort="Fernandez Due As, Victor" uniqKey="Fernandez Due As V" first="Víctor" last="Fernández-Due As">Víctor Fernández-Due As</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain. Electronic address: vfernandez@ub.edu.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author><author><name sortKey="Ciruela, Francisco" sort="Ciruela, Francisco" uniqKey="Ciruela F" first="Francisco" last="Ciruela">Francisco Ciruela</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain; Department of Physiology, Faculty of Sciences, University of Ghent, 9000 Gent, Belgium. Electronic address: fciruela@ub.edu.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain; Department of Physiology, Faculty of Sciences, University of Ghent, 9000 Gent</wicri:regionArea><placeName><region type="province" nuts="2">Province de Flandre-Orientale</region><settlement type="city">Gand</settlement><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25862943</idno><idno type="pmid">25862943</idno><idno type="doi">10.1016/j.bbr.2015.04.001</idno><idno type="wicri:Area/PubMed/Corpus">000463</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000463</idno><idno type="wicri:Area/PubMed/Curation">000463</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000463</idno><idno type="wicri:Area/PubMed/Checkpoint">000463</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000463</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.</title><author><name sortKey="Gandia, Jorge" sort="Gandia, Jorge" uniqKey="Gandia J" first="Jorge" last="Gandía">Jorge Gandía</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author><author><name sortKey="Morat, Xavier" sort="Morat, Xavier" uniqKey="Morat X" first="Xavier" last="Morat">Xavier Morat</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author><author><name sortKey="Stagljar, Igor" sort="Stagljar, Igor" uniqKey="Stagljar I" first="Igor" last="Stagljar">Igor Stagljar</name><affiliation wicri:level="4"><nlm:affiliation>Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, Donnelly Centre, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Fernandez Due As, Victor" sort="Fernandez Due As, Victor" uniqKey="Fernandez Due As V" first="Víctor" last="Fernández-Due As">Víctor Fernández-Due As</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain. Electronic address: vfernandez@ub.edu.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author><author><name sortKey="Ciruela, Francisco" sort="Ciruela, Francisco" uniqKey="Ciruela F" first="Francisco" last="Ciruela">Francisco Ciruela</name><affiliation wicri:level="4"><nlm:affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain; Department of Physiology, Faculty of Sciences, University of Ghent, 9000 Gent, Belgium. Electronic address: fciruela@ub.edu.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain; Department of Physiology, Faculty of Sciences, University of Ghent, 9000 Gent</wicri:regionArea><placeName><region type="province" nuts="2">Province de Flandre-Orientale</region><settlement type="city">Gand</settlement><settlement type="city">Barcelone</settlement></placeName><orgName type="university">Université de Barcelone</orgName></affiliation></author></analytic><series><title level="j">Behavioural brain research</title><idno type="eISSN">1872-7549</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine A2 Receptor Antagonists (pharmacology)</term><term>Animals</term><term>Jaw (drug effects)</term><term>Jaw (physiopathology)</term><term>Male</term><term>Mice, Inbred C57BL</term><term>Mice, Knockout</term><term>Movement (drug effects)</term><term>Movement (physiology)</term><term>Muscarinic Antagonists (pharmacology)</term><term>Parkinsonian Disorders (drug therapy)</term><term>Parkinsonian Disorders (physiopathology)</term><term>Pilocarpine</term><term>Pyrimidines (pharmacology)</term><term>Receptor, Adenosine A2A (metabolism)</term><term>Receptors, G-Protein-Coupled (genetics)</term><term>Receptors, G-Protein-Coupled (metabolism)</term><term>Tremor (drug therapy)</term><term>Tremor (physiopathology)</term><term>Triazoles (pharmacology)</term><term>Tropicamide (pharmacology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Receptors, G-Protein-Coupled</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Receptor, Adenosine A2A</term><term>Receptors, G-Protein-Coupled</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Adenosine A2 Receptor Antagonists</term><term>Muscarinic Antagonists</term><term>Pyrimidines</term><term>Triazoles</term><term>Tropicamide</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Jaw</term><term>Movement</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinsonian Disorders</term><term>Tremor</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Movement</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Jaw</term><term>Parkinsonian Disorders</term><term>Tremor</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Male</term><term>Mice, Inbred C57BL</term><term>Mice, Knockout</term><term>Pilocarpine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">GPR37, also known as parkin associated endothelin-like receptor (Pael-R), is an orphan GPCR that aggregates intracellularly in a juvenile form of Parkinson's disease. However, little is known about the function of this orphan receptor. Here, using a model for parkisonian tremor, the pilocarpine-induced tremulous jaw movements (TJMs), we show that the deletion of GPR37 attenuated the TJMs in response to this cholinomimetic. Interestingly, the control that adenosine A2A receptor exerted over TJMs was lost in the absence of GPR37, thus pointing to a pivotal role of this orphan receptor in the adenosinergic control of parkinsonian tremor.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25862943</PMID><DateCreated><Year>2015</Year><Month>05</Month><Day>13</Day></DateCreated><DateCompleted><Year>2016</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2015</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7549</ISSN><JournalIssue CitedMedium="Internet"><Volume>288</Volume><PubDate><Year>2015</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Behavioural brain research</Title><ISOAbbreviation>Behav. Brain Res.</ISOAbbreviation></Journal><ArticleTitle>Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.</ArticleTitle><Pagination><MedlinePgn>103-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbr.2015.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-4328(15)00243-0</ELocationID><Abstract><AbstractText>GPR37, also known as parkin associated endothelin-like receptor (Pael-R), is an orphan GPCR that aggregates intracellularly in a juvenile form of Parkinson's disease. However, little is known about the function of this orphan receptor. Here, using a model for parkisonian tremor, the pilocarpine-induced tremulous jaw movements (TJMs), we show that the deletion of GPR37 attenuated the TJMs in response to this cholinomimetic. Interestingly, the control that adenosine A2A receptor exerted over TJMs was lost in the absence of GPR37, thus pointing to a pivotal role of this orphan receptor in the adenosinergic control of parkinsonian tremor.</AbstractText><CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gandía</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morató</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stagljar</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Dueñas</LastName><ForeName>Víctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain. Electronic address: vfernandez@ub.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciruela</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain; Department of Physiology, Faculty of Sciences, University of Ghent, 9000 Gent, Belgium. Electronic address: fciruela@ub.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Behav Brain Res</MedlineTA><NlmUniqueID>8004872</NlmUniqueID><ISSNLinking>0166-4328</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C098657">5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058917">Adenosine A2 Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509804">Gpr37 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018727">Muscarinic Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043705">Receptor, Adenosine A2A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014230">Triazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>01MI4Q9DI3</RegistryNumber><NameOfSubstance UI="D010862">Pilocarpine</NameOfSubstance></Chemical><Chemical><RegistryNumber>N0A3Z5XTC6</RegistryNumber><NameOfSubstance UI="D014331">Tropicamide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058917" MajorTopicYN="N">Adenosine A2 Receptor Antagonists</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007568" MajorTopicYN="N">Jaw</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009068" MajorTopicYN="N">Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018727" MajorTopicYN="N">Muscarinic Antagonists</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010862" MajorTopicYN="N">Pilocarpine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043705" MajorTopicYN="N">Receptor, Adenosine A2A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014202" MajorTopicYN="N">Tremor</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014230" MajorTopicYN="N">Triazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014331" MajorTopicYN="N">Tropicamide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GPR37</Keyword><Keyword MajorTopicYN="N">Orphan receptor</Keyword><Keyword MajorTopicYN="N">Pael-R</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">Tremulous jaw movement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25862943</ArticleId><ArticleId IdType="pii">S0166-4328(15)00243-0</ArticleId><ArticleId IdType="doi">10.1016/j.bbr.2015.04.001</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Belgique</li><li>Canada</li><li>Espagne</li></country><region><li>Catalogne</li><li>Ontario</li><li>Province de Flandre-Orientale</li></region><settlement><li>Barcelone</li><li>Gand</li><li>Toronto</li></settlement><orgName><li>Université de Barcelone</li><li>Université de Toronto</li></orgName></list><tree><country name="Espagne"><region name="Catalogne"><name sortKey="Gandia, Jorge" sort="Gandia, Jorge" uniqKey="Gandia J" first="Jorge" last="Gandía">Jorge Gandía</name></region><name sortKey="Fernandez Due As, Victor" sort="Fernandez Due As, Victor" uniqKey="Fernandez Due As V" first="Víctor" last="Fernández-Due As">Víctor Fernández-Due As</name><name sortKey="Morat, Xavier" sort="Morat, Xavier" uniqKey="Morat X" first="Xavier" last="Morat">Xavier Morat</name></country><country name="Canada"><region name="Ontario"><name sortKey="Stagljar, Igor" sort="Stagljar, Igor" uniqKey="Stagljar I" first="Igor" last="Stagljar">Igor Stagljar</name></region></country><country name="Belgique"><region name="Province de Flandre-Orientale"><name sortKey="Ciruela, Francisco" sort="Ciruela, Francisco" uniqKey="Ciruela F" first="Francisco" last="Ciruela">Francisco Ciruela</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000591 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000591 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25862943
|texte= Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25862943" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |